Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
ANI Pharmaceuticals Inc (ANIP)
NASDAQ:ANIP
ANI Pharmaceuticals (ANIP) Stock Price & Analysis
228 Followers
ANIP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$22.31 - $45.50
Previous Close$45.08
Volume52.01K
Average Volume (3M)74.59K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$56.28M
Total Debt (Recent Filing)$286.73M
Price to Earnings (P/E)-10.1
Beta0.78
Next EarningsMar 02, 2023
EPS Estimate$0.7
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$50.00
EPS (TTM)-4.48
Shares Outstanding17,453,805
R-Squared0.22
Standard Deviation0.12
10 Day Avg. Volume51,316
30 Day Avg. Volume74,594
Price to Book (P/B)40.31
Price to Sales (P/S)3.48
Price to Cash Flow (P/CF)100.40
P/FCF Ratio-18.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside9.36% Upside
Rating ConsensusModerate Buy
Alpha-0.00741
Number of Analyst Covering2
ANI Pharmaceuticals News
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ANIP FAQ
What was ANI Pharmaceuticals’s price range in the past 12 months?
ANI Pharmaceuticals lowest stock price was $22.31 and its highest was $45.50 in the past 12 months.
What is ANI Pharmaceuticals’s market cap?
Currently, no data Available
When is ANI Pharmaceuticals’s upcoming earnings report date?
ANI Pharmaceuticals’s upcoming earnings report date is Mar 02, 2023 which is in 22 days.
How were ANI Pharmaceuticals’s earnings last quarter?
ANI Pharmaceuticals released its earnings results on Nov 09, 2022. The company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.552 by $0.088.
Is ANI Pharmaceuticals overvalued?
According to Wall Street analysts ANI Pharmaceuticals’s price is currently Undervalued.
Does ANI Pharmaceuticals pay dividends?
ANI Pharmaceuticals does not currently pay dividends.
What is ANI Pharmaceuticals’s EPS estimate?
ANI Pharmaceuticals’s EPS estimate is $0.7.
How many shares outstanding does ANI Pharmaceuticals have?
ANI Pharmaceuticals has 17,453,806 shares outstanding.
What happened to ANI Pharmaceuticals’s price movement after its last earnings report?
ANI Pharmaceuticals reported an EPS of $0.64 in its last earnings report, beating expectations of $0.552. Following the earnings report the stock price went down -9.2%.
Which hedge fund is a major shareholder of ANI Pharmaceuticals?
Among the largest hedge funds holding ANI Pharmaceuticals’s share is Defender Capital, LLC.. It holds ANI Pharmaceuticals’s shares valued at 771K.
---
ANI Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$50.00
$50.00
Blogger Sentiment
Bullish
ANIP Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.48%
12-Months-Change
Fundamentals
Return on Equity
-25.67%
Trailing 12-Months
Asset Growth
57.11%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
ANI Pharmaceuticals Inc
ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
---
Collegium Pharmaceutical
―
Belite Bio, Inc. ADR
―
Provention Bio
―
Third Harmonic Bio, Inc.
―
---